https://www.pharmacytimes.com/view/fda-approves-selarsdi-as-biosimlar-to-stelara-in-an-intravenous-formulation
In April 2024, the FDA approved ustekinumab-aekn as a subcutaneous injection for the treatment of moderate to severe plaque psoriasis and active psoriatic...
fdaselarsdistelaraintravenous